Treatment of visceral leishmaniasis: Efficacy and limits of miltefosine;Traitement de la leishmaniose viscérale: Le point sur l'intérêt et les limites de la miltéfosine

Cahiers Sante

Volumn 11, Issue 4, 2001, Pages 257-258

  Gangneux, Jean Pierre ^a   Marty, Pierre ^a  

^a RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; MILTEFOSINE; PAROMOMYCIN;

CLINICAL PROTOCOL; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; IMMUNOCOMPETENCE; SHORT SURVEY; VISCERAL LEISHMANIASIS;

ADMINISTRATION, ORAL; ADOLESCENT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTIPROTOZOAL AGENTS; CHILD; CLINICAL TRIALS; FEMALE; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MALE; MICE; MICE, NUDE; PHOSPHORYLCHOLINE; PREGNANCY; TIME FACTORS;

EID: 0035722569     PISSN: 11575999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (16)

1. Données récentes sur le traitement de la leishmaniose viscérale
2. The activities of four anti-cancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei
3. Hexadecylphosphocholine: Oral treatment of visceral leishmaniasis in mice
4. Trial of oral miltefosine for visceral leishmaniasis
5. Oral treatment of visceral leishmaniasis with miltefosine
6. Miltefosine, an oral agent, for the treatment of indian visceral leishmaniasis
7. Short-course of oral miltefodine for treatment of visceral leishmaniasis
8. Miltefosine in indian visceral leishmaniasis
9. Visceral leishmanicidal activity of hexadecylphosphocholine (Miltefosine) in mice deficient in T-cells and activated macrophage microbicidal mechanisms
10. Role of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis
11. Suppression of posttreatment recurrence of experimental visceral leishmaniasis in T-cell-deficient mice by oral miltefosine
12. Treatment of experimental visceral leishmaniasis in T-cell-deficient host: Response to amphotericin B and pentamidine
13. Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in India
14. Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BalB/c mice
15. Treatment of VL/HIV co-infected patients with oral miltefosine